|
Market Closed -
Toronto S.E.
21:00:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 10.12 CAD | +12.20% |
|
+6.08% | +27.78% |
| 10-27 | Satellos Bioscience Inc. Announces Management Changes | CI |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 152M | - | - | - | - | - |
| 65.94B | |||||
| 56.53B | |||||
| 56.88B | |||||
| 46.49B | |||||
| 44.8B |
Select your edition
All financial news and data tailored to specific country editions
